Puma Biotechnology, Inc.
PBYI
$8.83
$0.121.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 318.20% | -127.93% | 51.94% | 51.05% | 96.87% |
| Total Depreciation and Amortization | -2.63% | 39.15% | -31.78% | -1.48% | -1.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.68% | -60.88% | 232.10% | 15.64% | -43.46% |
| Change in Net Operating Assets | -175.15% | 324.58% | -95.69% | -179.59% | 195.47% |
| Cash from Operations | -89.47% | 6.91% | 48.82% | -31.20% | 289.87% |
| Capital Expenditure | -- | -- | 238.46% | -30.00% | 67.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 222.23% | 109.16% | -5,177.63% | 104.74% | -805.28% |
| Cash from Investing | 222.23% | 109.17% | -5,431.42% | 104.50% | -834.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.09% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.45% | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash from Financing | -0.10% | 0.00% | 0.00% | -1.16% | 1.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -126.64% | 127.45% | -2,001.14% | 86.41% | -35.21% |